Literature DB >> 7813456

Identification and biosynthesis of N1,N9-bis(glutathionyl)aminopropylcadaverine (homotrypanothione) in Trypanosoma cruzi.

K J Hunter1, S A Le Quesne, A H Fairlamb.   

Abstract

Radiolabelling studies using tritiated ornithine, arginine and lysine, together with the relevant amino acid decarboxylase enzyme assays, indicate that the epimastigote stage of Trypanosoma cruzi is unable to synthesise significant amounts of putrescine and cadaverine de novo, compared to the amounts of these diamines scavenged from the growth medium. Radiolabelled putrescine is readily incorporated into spermidine, spermine and the trypanosomatid-specific polyamine-glutathione conjugate trypanothione (N1,N8-bis(glutathionyl)spermidine). Likewise, radiolabelled cadaverine is incorporated into the analogous polyamines aminopropylcadaverine, bis(aminopropyl)cadaverine and another major unidentified component. Subsequent studies showed this major component to be a novel polyamine-thiol conjugate whose structure was confirmed by chemical synthesis to be N1,N9-bis(glutathionyl)aminopropylcadaverine (homotrypanothione). Kinetic analyses using recombinant T. cruzi trypanothione reductase demonstrated that homotrypanothione disulphide is readily reduced by this enzyme with kinetic parameters similar to trypanothione disulphide, suggesting that it is a physiological substrate in vivo. Thus the epimastigote form of T. cruzi differs significantly from the African trypanosomes and Leishmania in (a) being unable to synthesise significant amounts of diamines de novo, (b) converting significant amounts of putrescine and cadaverine to spermine and bis(aminopropyl)cadaverine, respectively and (c) the ability to synthesise homotrypanothione as well as trypanothione. The implications of these findings with respect to the prospective chemotherapy of Chagas' disease are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7813456     DOI: 10.1111/j.1432-1033.1994.t01-1-01019.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  20 in total

1.  The crystal structure of trypanothione reductase from the human pathogen Trypanosoma cruzi at 2.3 A resolution.

Authors:  Y Zhang; C S Bond; S Bailey; M L Cunningham; A H Fairlamb; W N Hunter
Journal:  Protein Sci       Date:  1996-01       Impact factor: 6.725

2.  A high-affinity putrescine-cadaverine transporter from Trypanosoma cruzi.

Authors:  Marie-Pierre Hasne; Isabelle Coppens; Radika Soysa; Buddy Ullman
Journal:  Mol Microbiol       Date:  2010-02-10       Impact factor: 3.501

3.  Metabolomic profiling reveals a finely tuned, starvation-induced metabolic switch in Trypanosoma cruzi epimastigotes.

Authors:  María Julia Barisón; Ludmila Nakamura Rapado; Emilio F Merino; Elizabeth Mieko Furusho Pral; Brian Suarez Mantilla; Letícia Marchese; Cristina Nowicki; Ariel Mariano Silber; Maria Belen Cassera
Journal:  J Biol Chem       Date:  2017-03-29       Impact factor: 5.157

4.  TcGPXII, a glutathione-dependent Trypanosoma cruzi peroxidase with substrate specificity restricted to fatty acid and phospholipid hydroperoxides, is localized to the endoplasmic reticulum.

Authors:  Shane R Wilkinson; Martin C Taylor; Said Touitha; Isabel L Mauricio; David J Meyer; John M Kelly
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

5.  Regulation of a high-affinity diamine transport system in Trypanosoma cruzi epimastigotes.

Authors:  S A Le Quesne; A H Fairlamb
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

6.  Sugar nucleotide pools of Trypanosoma brucei, Trypanosoma cruzi, and Leishmania major.

Authors:  Daniel C Turnock; Michael A J Ferguson
Journal:  Eukaryot Cell       Date:  2007-06-08

7.  Trypanosoma cruzi has not lost its S-adenosylmethionine decarboxylase: characterization of the gene and the encoded enzyme.

Authors:  K Persson; L Aslund; B Grahn; J Hanke; O Heby
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

8.  Identification of a Proteasome-Targeting Arylsulfonamide with Potential for the Treatment of Chagas' Disease.

Authors:  Marta L Lima; Lindsay B Tulloch; Victoriano Corpas-Lopez; Sandra Carvalho; Richard J Wall; Rachel Milne; Eva Rico; Stephen Patterson; Ian H Gilbert; Sonia Moniz; Lorna MacLean; Leah S Torrie; Carmine Morgillo; David Horn; Fabio Zuccotto; Susan Wyllie
Journal:  Antimicrob Agents Chemother       Date:  2021-10-04       Impact factor: 5.191

Review 9.  Polyamine homoeostasis as a drug target in pathogenic protozoa: peculiarities and possibilities.

Authors:  Lyn-Marie Birkholtz; Marni Williams; Jandeli Niemand; Abraham I Louw; Lo Persson; Olle Heby
Journal:  Biochem J       Date:  2011-09-01       Impact factor: 3.857

10.  Biochemical and genetic characterization of Trypanosoma cruzi N-myristoyltransferase.

Authors:  Adam J Roberts; Leah S Torrie; Susan Wyllie; Alan H Fairlamb
Journal:  Biochem J       Date:  2014-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.